Capecitabine Impurity 3, also known as Defluoro Capecitabine, is a chemical compound that serves as an impurity in the synthesis of the anticancer drug capecitabine. It is characterized by the absence of fluorine atoms that are typically present in the capecitabine structure, which can influence its pharmacological properties. The compound has a specific molecular structure that includes a pyrimidine ring and a carbamate moiety, contributing to its chemical reactivity and stability. Its CAS number, 216450-02-1, allows for precise identification in chemical databases. As an impurity, Defluoro Capecitabine may exhibit different solubility and stability profiles compared to the parent compound, which can affect the overall quality and efficacy of pharmaceutical formulations. Understanding the characteristics of this impurity is crucial for quality control in drug manufacturing, ensuring that the final product meets regulatory standards for safety and efficacy. Additionally, its presence can provide insights into the synthesis process and potential degradation pathways of capecitabine.

Capecitabine Impurity 3
 (Defluoro Capecitabine)

216450-02-1: Capecitabine Impurity 3, also known as Defluoro Capecitabine, is a chemical compound that serves as an impurity in the synthesis of the anticancer drug capecitabine. It is characterized by the absence of fluorine atoms that are typically present in the capecitabine structure, which can influence its pharmacological properties. The compound has a specific molecular structure that includes a pyrimidine ring and a carbamate moiety, contributing to its chemical reactivity and stability. Its CAS number, 216450-02-1, allows for precise identification in chemical databases. As an impurity, Defluoro Capecitabine may exhibit different solubility and stability profiles compared to the parent compound, which can affect the overall quality and efficacy of pharmaceutical formulations. Understanding the characteristics of this impurity is crucial for quality control in drug manufacturing, ensuring that the final product meets regulatory standards for safety and efficacy. Additionally, its presence can provide insights into the synthesis process and potential degradation pathways of capecitabine.

CAS 216450-02-1

Capecitabine Impurity 3 (Defluoro Capecitabine)

Capecitabine Impurity 3

Ref: ST-EA-CP-C52016